Literature DB >> 17999185

Serum prolidase and IGF-1 as non-invasive markers of hepatic fibrosis during four different periods after bile-duct ligation in rats.

Orhan Tarçin1, Nursal Gedik, Berna Karakoyun, Veysel Tahan, Gagan Sood, Ciğdem Celikel, Nurdan Tözün.   

Abstract

AIM: Our aim was to study the correlation of serum prolidase and insulin like growth factor-1 to liver collagen and assess their utility as markers of fibrosis during four different periods of hepatic injury and fibrosis after bile-duct ligation in rats.
METHODS: Forty-eight Wistar albino rats were included in the study and divided into six groups. Seven rats served as the control group (Control), while seven rats had a sham operation (Sham group). Thirty-four rats underwent bile-duct ligation. Bile-duct ligated (BDL) animals were sacrificed at the end of the first week (Group 1; n = 8), second week (Group 2; n = 8), third week (Group 3; n = 9), or fourth week (Group 4; n = 9) after BDL. Liver collagen, liver prolidase, and serum prolidase and IGF-I, were determined.
RESULTS: There was a positive correlation between liver collagen and serum prolidase (r(s): 0.843, P < 0.001) levels and a negative correlation among liver collagen and serum IGF-1 levels (r(s): -0.667, P < 0.001). The peak levels of liver collagen and serum prolidase were reached in the third week while the lowest levels of IGF-1 were found at the end of the third week.
CONCLUSION: Serum prolidase and IGF-1 either independently or in combination correlate with liver collagen content in hepatic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999185     DOI: 10.1007/s10620-007-0073-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

Review 1.  Insulin-like growth factors and their binding proteins.

Authors:  V R Sara; K Hall
Journal:  Physiol Rev       Date:  1990-07       Impact factor: 37.312

2.  The long-term pathological evolution of chronic hepatitis C.

Authors:  M Yano; H Kumada; M Kage; K Ikeda; K Shimamatsu; O Inoue; E Hashimoto; J H Lefkowitch; J Ludwig; K Okuda
Journal:  Hepatology       Date:  1996-06       Impact factor: 17.425

3.  Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.

Authors:  Thomas B Kelleher; Shruti H Mehta; Ramakrishnan Bhaskar; Mark Sulkowski; Jacquie Astemborski; David L Thomas; Richard E Moore; Nezam H Afdhal
Journal:  J Hepatol       Date:  2005-04-25       Impact factor: 25.083

4.  Collagens in the liver extracellular matrix bind hepatocyte growth factor.

Authors:  D Schuppan; M Schmid; R Somasundaram; R Ackermann; M Ruehl; T Nakamura; E O Riecken
Journal:  Gastroenterology       Date:  1998-01       Impact factor: 22.682

5.  Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

Authors:  Thierry Poynard; Mona Munteanu; Françoise Imbert-Bismut; Frederic Charlotte; Dominique Thabut; Sophie Le Calvez; Djamila Messous; Vincent Thibault; Yves Benhamou; Joseph Moussalli; Vlad Ratziu
Journal:  Clin Chem       Date:  2004-06-10       Impact factor: 8.327

6.  A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections.

Authors:  A López-De León; M Rojkind
Journal:  J Histochem Cytochem       Date:  1985-08       Impact factor: 2.479

7.  Plasma prolidase and prolinase activity in alcoholic liver disease.

Authors:  B Brosset; I Myara; M Fabre; A Lemonnier
Journal:  Clin Chim Acta       Date:  1988-07-29       Impact factor: 3.786

8.  Insulin-like growth factors (IGF) in liver disease: differential changes of IGF-I and IGF-II.

Authors:  M S Sheppard; G Y Minuk; B Bhaumick; R M Bala
Journal:  Clin Invest Med       Date:  1987-03       Impact factor: 0.825

9.  Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis.

Authors:  J Kratzsch; W F Blum; E Schenker; E Keller
Journal:  Exp Clin Endocrinol Diabetes       Date:  1995       Impact factor: 2.949

10.  In vivo inefficiency of pentoxifylline and interferon-alpha on hepatic fibrosis in biliary-obstructed rats: assessment by tissue collagen content and prolidase activity.

Authors:  Orhan Tarçin; Kadir Avşar; Levent Demirtürk; Mustafa Gültepe; Berna K Oktar; Osman C Ozdoğan; Ozlem Tarçin; Hüseyin Baloğlu; Ahmet K Gürbüz
Journal:  J Gastroenterol Hepatol       Date:  2003-04       Impact factor: 4.029

View more
  6 in total

1.  Evaluation of the utility of serum prolidase as a marker for liver fibrosis.

Authors:  John C Stanfliet; Michael Locketz; Peter Berman; Tahir S Pillay
Journal:  J Clin Lab Anal       Date:  2014-05-05       Impact factor: 2.352

2.  Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.

Authors:  Sevil Uygun Ilikhan; Muammer Bilici; Hatice Sahin; Ayşe Semra Demir Akca; Murat Can; Ibrahim Ilker Oz; Berrak Guven; M Cagatay Buyukuysal; Yucel Ustundag
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

3.  Prolidase could act as a diagnosis and treatment mediator in lung fibrosis.

Authors:  Ibrahim Türkbeyler; Tuncer Demir; Yavuz Pehlivan; Davut Sinan Kaplan; Ali Osman Ceribasi; Mustafa Orkmez; Nurten Aksoy; Seyithan Taysi; Bunyamin Kisacik; Ahmet Mesut Onat
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

4.  Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis.

Authors:  Huseyin Kayadibi; Mustafa Gültepe; Bulent Yasar; Ali T Ince; Omer Ozcan; Osman M Ipcioglu; Oya O Kurdas; Burhanettin Bolat; Yusuf Z Benek; Hakan Guveli; Sacide Atalay; Selvinaz Ozkara; Ozcan Keskin
Journal:  Dig Dis Sci       Date:  2008-11-07       Impact factor: 3.199

5.  Time course of collagen peak in bile duct-ligated rats.

Authors:  Orhan Tarcin; Metin Basaranoglu; Veysel Tahan; Gülgün Tahan; Ilker Sücüllü; Nevin Yilmaz; Gagan Sood; Ned Snyder; Gilbert Hilman; Cigdem Celikel; Nurdan Tözün
Journal:  BMC Gastroenterol       Date:  2011-04-28       Impact factor: 3.067

6.  Novel transcriptional profile in wrist muscles from cerebral palsy patients.

Authors:  Lucas R Smith; Eva Pontén; Yvette Hedström; Samuel R Ward; Henry G Chambers; Shankar Subramaniam; Richard L Lieber
Journal:  BMC Med Genomics       Date:  2009-07-14       Impact factor: 3.063

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.